PositiveID Corporation (OTCQB: PSID) is an emerging growth company that develops biological detection and diagnostic systems for America's homeland defense and the global healthcare market. PositiveID specializes in microfluidic systems for the automated preparation and performance of biological assays in order to detect biological threats and outbreaks whether airborne, in a healthcare setting, or at the point of need.

View all »   RSSRecent Releases

Apr 15, 2015
PositiveID Announces First Quarter Highlights

Apr 2, 2015
PositiveID Successfully Detects Multiple Organisms From a Single Assay on Its Firefly Dx PCR Chip